Advisers: Avandia should stay on market
(AP)
<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20070730/ap_on_he_me/diabetes_drug"><img src="http://d.yimg.com/us.yimg.com/p/ap/20070730/capt.536b2043aad64a8eab4de3a4f52266b3.diabetes_drugs_gfx225.jpg?x=130&y=84&sig=nea.MIUFR0YLgkoeTMhscw--" align="left" height="84" width="130" alt="Chart shows prescriptions written and sales for top diabetes drugs; 2c x 2 3/8 inches; 96.3 mm x 60.3 mm" border="0" /></a>AP - The widely used diabetes drug Avandia should remain on the market, government health advisers overwhelmingly recommended Monday, saying evidence of an increased risk of heart attack doesn't merit removal.</p><br clear="all"/>

Read more...